In particular, local administration of IL-12 has been shown to activate or reactivate tumor infiltrating CD8+ T cells, improve antigen presenting machinery and subsequently cause the expansion of tumor-specific CD8+ effector T cells. Here, CD8A is linked to neoplasm.